NNVC

NanoViricides, Inc. NNVC

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode NNVC VRCA JSPR SABS GBIO EVAX IGC QTTB MAIA ANTX
6M -6.10 % 43.40 % -69.16 % 112.36 % 57.32 % 92.66 % -5.71 % 99.68 % -15.52 % 2.78 %
YTD -18.66 % 18.92 % -91.68 % 1.89 % -49.68 % 8.01 % -18.12 % -10.29 % -29.67 % -20.14 %
1Y -23.51 % 28.81 % -92.20 % -9.57 % -49.68 % 17.97 % -20.57 % -13.55 % -27.94 % -19.57 %
3Y 2.21 % -66.15 % -69.90 % -41.85 % -85.34 % -94.42 % -5.44 % -85.05 % -54.77 % -88.00 %
5Y -65.42 % -92.83 % -98.27 % -96.28 % -98.37 % -98.99 % -83.20 % -98.60 % -67.04 % -92.79 %
10Y -95.42 % -95.22 % -98.21 % -96.28 % -97.74 % -98.99 % 32.80 % -99.08 % -67.04 % -92.79 %
From the beginning -96.70 % -95.22 % -98.21 % -96.28 % -97.74 % -98.99 % -99.47 % -99.08 % -67.04 % -92.79 %

Dividend

AN2 Therapeutics, Inc.